Physician profile
John C Daw
NPI 1700960291
$571.19
in general payments reported to CMS, 2019-2025
5 companies · $69.42 in 2025
The $69.42 reported for 2025 was less than what a typical Sports Vision provider received nationally (typical 2025 total: $83.61).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.27 · 2022: $134 · 2023: $177 · 2024: $125 · 2025: $69.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $316.79 | 2022-2025 | Cvi Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $133.32 | 2021-2025 | Precision7, Total30 |
| Glaukos Corporation | $49.64 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $40.40 | 2022-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $31.04 | 2023 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Daw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.